Home›Companies›Biotech & Pharma›RheoTek Medical

RheoTek Medical LLC

Updated Oct 29, 2026·Latest SEC filing Sep 6, 2024·Suggest an edit

About RheoTek Medical

RheoTek Medical is a private company based in New York, New York, incorporated in 2020 in Delaware. It has reported $1,085,000 raised in one offering on Form D since September 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 31, 2023Sep 12, 2023amended Sep 6, 2024$1,085,000of $4.0M target15$72,333Options, Securities on exercise, Simple agreement for future equityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on RheoTek Medical's Form D filed Sep 6, 2024.

DM
Daniel Mazzaferro
President and director
SB
Scott Bartlett
Executive officer and director
SD
Steven Duddy
Executive officer and director

Sources

  1. SECRheoTek Medical LLC Form D, filed Sep 12, 2023
  2. SECRheoTek Medical LLC filing history